3-D PROTEIN STRUCTURAL INFORMATION ENABLES DRUG DISCOVERY.Privately-held Structural Bioinformatics Structural bioinformatics refers to the branch of bioinformatics which is related to the analysis and prediction of the three-dimensional structure of biological macromolecules such as proteins. Inc. (SBI SBI Special Background Investigation SBI Subsidiary Body for Implementation SBI State Bank of India SBI Secure Border Initiative SBI Small Business Institute SBI Stockholm Brain Institute SBI Serious Bacterial Infection SBI Society of Breast Imaging ), San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , has announced that De Novo [Latin, Anew.] A second time; afresh. A trial or a hearing that is ordered by an appellate court that has reviewed the record of a hearing in a lower court and sent the matter back to the original court for a new trial, as if it had not been previously heard nor decided. Pharmaceuticals (Cambridge, UK) has entered into an agreement to access multiple therapeutic target classes within SBI's SBdBase, one of the databases within SBI's ProMax 3-dimensional protein structure database series. Dr. David Bailey David Bailey may refer to:
"The life sciences research community is now beginning to accept and demand the types of products and services we offer," said Dr. Edward T. Maggio, chairman, president and chief executive officer of SBI. "We are pleased to be working with De Novo Pharmaceuticals as further validation of the value and utility of large-scale protein structural information as we assist De Novo in meeting their customers' discovery objectives." De Novo Pharmaceuticals Ltd. De Novo Pharmaceuticals uses its proprietary computational Having to do with calculations. Something that is "highly computational" requires a large number of calculations. software for drug design to create novel, patentable lead molecules as candidates for drug development either through its in-house research or with its partners. De Novo's proprietary algorithms can convert information from structural genomics Noun 1. structural genomics - the branch of genomics that determines the three-dimensional structures of proteins genomics - the branch of genetics that studies organisms in terms of their genomes (their full DNA sequences) and medicinal chemistry Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacology involved with designing, synthesizing and developing pharmaceutical drugs. rapidly into new chemical designs, maximizing value within a pharmaceutical partner's research portfolio. De Novo has existing collaborations with British Biotechnology Ltd. and Aventis Pharma Inc. under its "Drug Design Partnership Program." Structural Bioinformatics Inc. SBI is a world leader in computational proteomics -- the large-scale generation and use of protein structure and protein structural information. The company has developed advanced technologies to generate highly refined 3-dimensional structural models of proteins from primary genetic information and commercializes these technologies through its structural database products and through drug discovery collaborations with leading pharmaceutical companies. SBI has offices in San Diego, Cambridge, Mass. and H0rsholm, Denmark. For more information, call 858/675-2400 or visit http://www.strubix.com/. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion